Page 1 | Search Results | Hematology, ASH Education Program

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Integrating patient-centered factors in the risk assessment of MDS

Rena J. Buckstein

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 373–380.

https://doi.org/10.1182/hematology.2019000041

Published: 2019

Journal Articles

Second-line therapies in immune thrombocytopenia

Rachael F. Grace, Cindy Neunert

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 698–706.

https://doi.org/10.1182/asheducation-2016.1.698

Published: 2016

Journal Articles

Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment

Flora E. van Leeuwen, Andrea K. Ng

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 323–330.

https://doi.org/10.1182/asheducation-2016.1.323

Published: 2016

Journal Articles

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Noelle V. Frey, David L. Porter

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 567–572.

https://doi.org/10.1182/asheducation-2016.1.567

Published: 2016

Journal Articles

First-line therapy for young patients with CLL

Nitin Jain, Susan O’Brien

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 146–148.

https://doi.org/10.1182/asheducation-2016.1.146

Published: 2016

Journal Articles

Do somatic mutations in de novo MDS predict for response to treatment?

Mark A. Schroeder, Amy E. DeZern

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 317–328.

https://doi.org/10.1182/asheducation-2015.1.317

Published: 2015

Journal Articles

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when is this a safe option to consider?

Kendra Sweet, Vivian Oehler

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 184–188.

https://doi.org/10.1182/asheducation-2013.1.184

Published: 2013

Journal Articles

Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?

Mark A. Schroeder, William Blum

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 322–324.

https://doi.org/10.1182/asheducation-2010.1.322

Published: 2010

Journal Articles

ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?

Monica S. Thakar, Stephen J. Forman

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 414–418.

https://doi.org/10.1182/asheducation-2009.1.414

Published: 2009

Journal Articles

Management of RBC-Transfusion Dependence

Magda Melchert, Alan F. List

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 398–404.

https://doi.org/10.1182/asheducation-2007.1.398

Published: 2007

Journal Articles

New Insights into Paroxysmal Nocturnal Hemoglobinuria

Robert A. Brodsky

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 24–28.

https://doi.org/10.1182/asheducation-2006.1.24

Published: 2006

NARROW

Integrating patient-centered factors in the risk assessment of MDS

Second-line therapies in immune thrombocytopenia

Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

First-line therapy for young patients with CLL

Do somatic mutations in de novo MDS predict for response to treatment?

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when is this a safe option to consider?

Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?

ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?

Management of RBC-Transfusion Dependence

New Insights into Paroxysmal Nocturnal Hemoglobinuria

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only